The Divine Word University Centre for Health Research & Diagnostics was established (CHRD) in 2010. The mission of the Centre is to promote and advance health and medical research. The Centre is not limited to research but also provide opportunities for training, student learning, service, and health policy advocacy. The Centre has identified four Key Research Areas (KRAs) for which it is focused in its research endeavors where University academic staff can be affiliated and conduct research in anyone of the KRAs. The Center also provides diagnostic services to clients, students, and community.
Professor Francis W. Hombhanje MD
Director Centre for Health Research and Diagnostics
Mr. Joseph Pawiying, BMLS – Laboratory scientist/Technologist & Laboratory Manager
Ms Cathy Kupe, BMLS - Laboratory scientist/Technologist
The Centre has identified five key research areas (KRAs) which provide the platform for research. Research can be conducted within any of the KRA as outlined:
KRA1: Clinical Research– which involves human subjects in hospital or in non-hospital settings.
KRA2: Health Services and health system Research – which involves research into health system and health care service delivery.
KRA3: Population and Public Health Research– which involves research into epidemiology, community health or socio-behaviour sciences.
KRA4: Biomedical Research – which involves basic/laboratory-based research
Collaborating Researcher Institutions
Department of International Affairs and Tropical Medicine
Tokyo Women’s Medical University, Tokyo, Japan
(Facilitator: Prof/Dr. Francis W. Hombhanje; Contact Person: Prof. Takahiro Tsukahara)
Juntendo University School of Medicine, Tokyo, Japan
(Facilitator: (Prof/Dr. Francis W. Hombhanje; Contact Person: Professor Toshihiro Mita)
Nossal Research Centre, University of Melbourne, Australia
(Facilitator: Ms Irene Semos)
Karolinska Instituet, Stockholm, Sweden
(Contact person: Prof. Akira Kaneko)
PNG University of Technology, Lae, Papua New Guinea
(Contact person Dr. Dr. Subramaniyam Kopalakrishanan)
- In-vitro and molecular monitoring of drug resistance in Plasmodium falciparum at the time of the introduction of artemisinin-based combination therapy (ACT) in Papua New Guinea (Lead investigator: Prof. Francis Hombhanje in collaboration with Prof. Toshihiro Mita)
- Antimicrobial drug resistant pattern at Surgery Department of Modilon General Hospital, Madang, Papua New Guinea (Lead investigator: Associate Prof. Jerzy Kuzma in collaboration with Prof. Francis Hombhanje)
- Investigation of pharmacology, genetics, and sociology in relation to antimalarial drugs and their implications for malaria control in Papua New Guinea. (Lead investigator: Dr. Takahiro Tsukahara in collaboration with Prof. Francis Hombhanje)
- Assessing the risks of treatment failure in implementing mg/kg – dosing strategies based on weight “banding” in paediatric malaria with Artemether-lumefantrine (AL) and artemisinin-naphthoquine (ANQ) combinations in Maprik rural health care facilities. (Lead investigator: Prof. Francis Hombhanje)
- Traditional best practice for HIV in Yangoru-Sausia, East Sepik Province, Papua New Guinea. (Lead investigator: Dr. Clement Manineng in collaboration with Prof. Francis Hombhanje)
- Documentation of herbal medicinal use among PLWHIV in East Sepik Province, Papua New Guinea. (Lead investigator: Dr. Clement Manineng in collaboration with Prof. Francis Hombhanje)
- A study to determine the safety and efficacy of adding thioridazine to DOTS therapy for six months in patients with pulmonary tuberculosis starting DOTS and MRD-TB treatment (Lead investigator: Dr. Martin Daimen in collaboration with Prof. Francis Hombhanje)